Literature DB >> 16672507

Two routes of metabolic cross-feeding between Bifidobacterium adolescentis and butyrate-producing anaerobes from the human gut.

Alvaro Belenguer1, Sylvia H Duncan, A Graham Calder, Grietje Holtrop, Petra Louis, Gerald E Lobley, Harry J Flint.   

Abstract

Dietary carbohydrates have the potential to influence diverse functional groups of bacteria within the human large intestine. Of 12 Bifidobacterium strains of human gut origin from seven species tested, four grew in pure culture on starch and nine on fructo-oligosaccharides. The potential for metabolic cross-feeding between Bifidobacterium adolescentis and lactate-utilizing, butyrate-producing Firmicute bacteria related to Eubacterium hallii and Anaerostipes caccae was investigated in vitro. E. hallii L2-7 and A. caccae L1-92 failed to grow on starch in pure culture, but in coculture with B. adolescentis L2-32 butyrate was formed, indicating cross-feeding of metabolites to the lactate utilizers. Studies with [(13)C]lactate confirmed carbon flow from lactate, via acetyl coenzyme A, to butyrate both in pure cultures of E. hallii and in cocultures with B. adolescentis. Similar results were obtained in cocultures involving B. adolescentis DSM 20083 with fructo-oligosaccharides as the substrate. Butyrate formation was also stimulated, however, in cocultures of B. adolescentis L2-32 grown on starch or fructo-oligosaccharides with Roseburia sp. strain A2-183, which produces butyrate but does not utilize lactate. This is probably a consequence of the release by B. adolescentis of oligosaccharides that are available to Roseburia sp. strain A2-183. We conclude that two distinct mechanisms of metabolic cross-feeding between B. adolescentis and butyrate-forming bacteria may operate in gut ecosystems, one due to consumption of fermentation end products (lactate and acetate) and the other due to cross-feeding of partial breakdown products from complex substrates.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16672507      PMCID: PMC1472403          DOI: 10.1128/AEM.72.5.3593-3599.2006

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  43 in total

1.  Extensive set of 16S rRNA-based probes for detection of bacteria in human feces.

Authors:  Hermie J M Harmsen; Gerwin C Raangs; Tao He; John E Degener; Gjalt W Welling
Journal:  Appl Environ Microbiol       Date:  2002-06       Impact factor: 4.792

2.  Restricted distribution of the butyrate kinase pathway among butyrate-producing bacteria from the human colon.

Authors:  Petra Louis; Sylvia H Duncan; Sheila I McCrae; Jacqueline Millar; Michelle S Jackson; Harry J Flint
Journal:  J Bacteriol       Date:  2004-04       Impact factor: 3.490

3.  Lactate is mainly fermented to butyrate by human intestinal microfloras but inter-individual variation is evident.

Authors:  C Bourriaud; R J Robins; L Martin; F Kozlowski; E Tenailleau; C Cherbut; C Michel
Journal:  J Appl Microbiol       Date:  2005       Impact factor: 3.772

4.  Development of 16S rRNA-gene-targeted group-specific primers for the detection and identification of predominant bacteria in human feces.

Authors:  Takahiro Matsuki; Koichi Watanabe; Junji Fujimoto; Yukiko Miyamoto; Toshihiko Takada; Kazumasa Matsumoto; Hiroshi Oyaizu; Ryuichiro Tanaka
Journal:  Appl Environ Microbiol       Date:  2002-11       Impact factor: 4.792

5.  pH and peptide supply can radically alter bacterial populations and short-chain fatty acid ratios within microbial communities from the human colon.

Authors:  Alan W Walker; Sylvia H Duncan; E Carol McWilliam Leitch; Matthew W Child; Harry J Flint
Journal:  Appl Environ Microbiol       Date:  2005-07       Impact factor: 4.792

Review 6.  Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics.

Authors:  G R Gibson; M B Roberfroid
Journal:  J Nutr       Date:  1995-06       Impact factor: 4.798

7.  Changes of fermentation pathways of fecal microbial communities associated with a drug treatment that increases dietary starch in the human colon.

Authors:  M J Wolin; T L Miller; S Yerry; Y Zhang; S Bank; G A Weaver
Journal:  Appl Environ Microbiol       Date:  1999-07       Impact factor: 4.792

8.  Synbiotic therapy (Bifidobacterium longum/Synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: a randomised controlled pilot trial.

Authors:  E Furrie; S Macfarlane; A Kennedy; J H Cummings; S V Walsh; D A O'neil; G T Macfarlane
Journal:  Gut       Date:  2005-02       Impact factor: 23.059

9.  Effects of lactulose and other laxatives on ileal and colonic pH as measured by a radiotelemetry device.

Authors:  R L Bown; J A Gibson; G E Sladen; B Hicks; A M Dawson
Journal:  Gut       Date:  1974-12       Impact factor: 23.059

Review 10.  Diet and cancer: assessing the risk.

Authors:  C I R Gill; I R Rowland
Journal:  Br J Nutr       Date:  2002-09       Impact factor: 3.718

View more
  213 in total

1.  Bifidobacterium animalis subsp. lactis fermented milk product reduces inflammation by altering a niche for colitogenic microbes.

Authors:  Patrick Veiga; Carey Ann Gallini; Chloé Beal; Monia Michaud; Mary L Delaney; Andrea DuBois; Artem Khlebnikov; Johan E T van Hylckama Vlieg; Shivesh Punit; Jonathan N Glickman; Andrew Onderdonk; Laurie H Glimcher; Wendy S Garrett
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-04       Impact factor: 11.205

2.  High-level dietary fibre up-regulates colonic fermentation and relative abundance of saccharolytic bacteria within the human faecal microbiota in vitro.

Authors:  Qing Shen; Lu Zhao; Kieran M Tuohy
Journal:  Eur J Nutr       Date:  2011-09-28       Impact factor: 5.614

3.  Tools for the tract: understanding the functionality of the gastrointestinal tract.

Authors:  Petia Kovatcheva-Datchary; Erwin G Zoetendal; Koen Venema; Willem M de Vos; Hauke Smidt
Journal:  Therap Adv Gastroenterol       Date:  2009-07       Impact factor: 4.409

4.  Gut microbiome compositional and functional differences between tumor and non-tumor adjacent tissues from cohorts from the US and Spain.

Authors:  Imane Allali; Susana Delgado; Pablo Isidro Marron; Aurora Astudillo; Jen Jen Yeh; Hassan Ghazal; Saaïd Amzazi; Temitope Keku; M Andrea Azcarate-Peril
Journal:  Gut Microbes       Date:  2015

5.  Development of a semiquantitative degenerate real-time pcr-based assay for estimation of numbers of butyryl-coenzyme A (CoA) CoA transferase genes in complex bacterial samples.

Authors:  Petra Louis; Harry J Flint
Journal:  Appl Environ Microbiol       Date:  2007-01-26       Impact factor: 4.792

6.  Culture-independent analyses of temporal variation of the dominant fecal microbiota and targeted bacterial subgroups in Crohn's disease.

Authors:  Pauline D Scanlan; Fergus Shanahan; Caitlin O'Mahony; Julian R Marchesi
Journal:  J Clin Microbiol       Date:  2006-09-20       Impact factor: 5.948

Review 7.  Environmental Factors, Gut Microbiota, and Colorectal Cancer Prevention.

Authors:  Mingyang Song; Andrew T Chan
Journal:  Clin Gastroenterol Hepatol       Date:  2018-07-18       Impact factor: 11.382

8.  Impact of pH on lactate formation and utilization by human fecal microbial communities.

Authors:  Alvaro Belenguer; Sylvia H Duncan; Grietje Holtrop; Susan E Anderson; Gerald E Lobley; Harry J Flint
Journal:  Appl Environ Microbiol       Date:  2007-08-31       Impact factor: 4.792

9.  Mucin Cross-Feeding of Infant Bifidobacteria and Eubacterium hallii.

Authors:  Vera Bunesova; Christophe Lacroix; Clarissa Schwab
Journal:  Microb Ecol       Date:  2017-07-18       Impact factor: 4.552

Review 10.  Healthy Human Gastrointestinal Microbiome: Composition and Function After a Decade of Exploration.

Authors:  Wenly Ruan; Melinda A Engevik; Jennifer K Spinler; James Versalovic
Journal:  Dig Dis Sci       Date:  2020-03       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.